BioXcel Therapeutics Stock Price - BTAI

1.06 (3.04%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
BioXcel Therapeutics Inc BTAI NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.69 2.02% 34.89 34.06 37.50 35.06 34.20 00:00:06
Bid Price Ask Price Spread Spread % News
34.96 36.57 1.61 4.4% 2 -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
7,396 911,127 $ 35.94 $ 32,745,490 662,552 3.76 - 43.6297
Last Trade Time Type Quantity Stock Price Currency
19:50:01 10 $ 35.95 USD

BioXcel Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 631.07M 18.09M $ -19.27M -1.33 - 17.90M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

BioXcel Therapeutics News

Date Time Source News Article
2/21/202006:05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
2/21/202006:01Edgar (US Regulatory)Current Report Filing (8-k)
2/20/202007:30GlobeNewswire Inc.BioXcel Therapeutics Announces Pricing of Public Offering of..
2/19/202017:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
2/19/202017:12Edgar (US Regulatory)Current Report Filing (8-k)
2/19/202017:08Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
2/19/202016:54GlobeNewswire Inc.BioXcel Therapeutics Announces Proposed Public Offering of..

Latest BTAI Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BTAI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week38.7343.629725.5136.952,604,641-3.84-9.91%
1 Month16.9043.629715.8731.29832,49217.99106.45%
3 Months6.3743.62975.5823.43475,13128.52447.72%
6 Months8.6943.62973.7619.84269,21826.20301.5%
1 Year8.1543.62973.7618.73155,22326.74328.1%
3 Years11.0243.62972.4115.14117,49823.87216.61%
5 Years11.0243.62972.4115.14117,49823.87216.61%

BioXcel Therapeutics Description

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company which is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, which is a sublingual thin film formulation of dexmedetomidine designed for acute treatment of agitation resulting from neurological and psychiatric disorders, and BXCL701, an immuno-oncology agent designed for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer. The company's other product candidates are BXCL502 and BXCL702 which is focused on neurodegeneration and hematological malignancies.
Your Recent History
BioXcel Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200222 19:00:59